# A Study in Adult Subjects With Select Advanced Solid Tumors

> **NCT02583165** · PHASE1 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 40 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **BIOLOGICAL:** MEDI1873

## Key facts

- **NCT ID:** NCT02583165
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-09
- **Primary completion:** 2018-12-19
- **Final completion:** 2018-12-19
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02583165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02583165, "A Study in Adult Subjects With Select Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02583165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*